Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Apr 28.
Published in final edited form as: J Agric Food Chem. 2010 Apr 28;58(8):4653–4659. doi: 10.1021/jf100398u

Structural Determination and Daily Variations of Porcine Milk Oligosaccharides

Nannan Tao *, Karen L Ochonicky , J Bruce German §, Sharon M Donovan , Carlito B Lebrilla *,#
PMCID: PMC2882034  NIHMSID: NIHMS194333  PMID: 20369835

Abstract

Free milk oligosaccharides (OS) is a major component of mammalian milk. Swine are important agricultural species and biomedical models. Despite their importance, little is known of the OS profile of porcine milk. Herein, the porcine milk glycome was elucidated and monitored over the entire lactation period by liquid chromatography profiling and structural determination with mass spectrometry. Milk was collected from second parity sows (n=3) at farrowing and on days 1, 4, 7 and 24 of lactation. Twenty-nine distinct porcine milk oligosaccharides (pMO) were identified. The pMO are highly sialylated, which is more similar to bovine milk than human milk OS. Six fucosylated pMO were detected at low levels in porcine milk, making it more similar to human milk than bovine. In general, the pMO content was highest in milk collected at farrowing and day 1 of lactation, decreased during early lactation, but then rose at day 24, however, the pMO displayed different patterns of variation across lactation. In summary, porcine milk contains both acidic (sialylated) and neutral (fucosylated) OS, but sialic-acid containing OS predominate throughout lactation.

Keywords: oligosaccharide, porcine milk, mass spectrometry, LCMS, bovine milk

INTRODUCTION

Milk oligosaccharides (OS) are relatively resistant to digestion (Engfer et al., 2000) and contribute to the anti-infective and prebiotic activities of milk (Bode, 2006; Kunz et al., 2000). Human milk is particularly rich in OS; containing 20–23 g/L in colostrum and 7–12 g/L in mature milk (Boehm and Stahl, 2007). In contrast, bovine milk, which forms the basis of most infant formulas, only contains ∼ 1/20th of the OS content (Tao et al., 2009). There are also marked differences in the structural diversity of the human milk (hMO) (Niñonuevo et al., 2006, 2008; German et al., 2008) and bovine milk (bMO) (Tao et al., 2009) OS. Swine are important agricultural species and are considered an excellent model for nutrition studies because of their digestive system physiology and anatomical structure (Baker et al., 2008; Patterson et al., 2008). Additionally, the developing brain structure and function resemble those of human infants (Pond et al., 2000). These similarities have led to an increased interest in characterizing porcine milk composition, however, little is known of the OS profile of porcine milk.

Milk OS are complex carbohydrates that are typically composed of 3 to 10 monosaccharides, which are covalently linked through glycosidic bonds to yield free OS with aldehyde reducing ends. Since OS are produced by the same enzymes as O-linked glycans, they tend to have structural similarities to O-glycans. The monomers that make up milk OS include D-glucose (Glc), D-galactose (Gal), N-acetylglucosamine (GlcNAc), L-fucose (Fuc), N-acetylneuraminic acid (NeuAc), and N-glycolylneuraminic acid (NeuGc) (Boehm and Stahl, 2007; Rivero-Urgel and Santamaria-Orleans, 2001). Fucose and neuraminic acids (or sialic acids) are found on the non-reducing end and are generally associated with important biological functions (Bode, 2006; Kunz et al., 2000). Fucose and sialic acids are known to bind to bacterial walls thereby preventing binding to epithelial cells (Nakano et al., 2001). For example, higher levels of fucosyloligosaccharides in human milk have been reported to protect against infant diarrhea (Newburg et al., 2004). Higher concentrations of sialic acids offer a higher level of protection from infection (Newburg et al., 2005).

Milk OS are also thought to modulate the neonatal microbiota by serving as a prebiotic (Boehm et al., 2005; German et al., 2005). The microbiota of breast- vs. formula-fed infants differs (Penders et al., 2006) and can be influenced by the addition of synthetic prebiotics (Rao et al., 2009). Recent work from our laboratory demonstrated that the microbiota of the breast-fed infant ferments specific human milk OS (LoCascio et al., 2007; Ward et al., 2006, 2007). For example, when five strains of bifidobacteria were tested (Bifidobacterium longum biovar infantis, Bifidobacterium bifidum, Bifidobacterium longum biovar longum, Bifidobacterium breve, and Bifidobacterium adolescentis), differences in their ability to utilize hMO for growth or to generate free sialic acid, fucose and N-acetylglucosamine were noted (Ward et al., 2007). B. longum bv. infantis demonstrated substantial degradation of hMO, whereas other strains demonstrated moderate (B. bifidum) or little degradation (B longum bv. longum, B. breve, and B. adolescentis). Thus, HMO may selectively promote the growth of certain bifidobacteria strains, and their catabolism may result in free monosaccharides in the colonic lumen.

In addition to their anti-infective and prebiotic activities within the gut, hMO can be absorbed and are excreted in the urine in breastfed infants (Kunz and Rudloff, 2008). As such, systemic effects have also been attributed to hMO. Due to their similarities to selectin ligands, the anti-inflammatory properties of hMOs have been tested in vitro. It has been shown that sialic acid-containing OS reduce the adhesion of leukocytes to endothelial cells, an indication for an immune regulatory effect of certain hMO (Bode et al., 2004).

Lastly, sialic acids have important roles in the development of infant brain; gangliosides make up 10% of the total lipid mass of brain tissue, with different numbers of negatively sialic acid moieties (Svennerholm et al., 1994; Wang et al., 1998). Neonates have a limited capacity for de novo endogenous synthesis of sialic acid (Gal et al., 1997). Data from neonatal models suggest that systemically-administered or dietary sialic acid is readily incorporated into the developing brain (Morgan and Winick, 1981) and may have functional outcomes (Wang et al., 2007). Approximately 80% of injected radiolabeled sialic acid was incorporated into the synaptosomal fraction of 12-day-old rat pups (Morgan and Winick, 1981). A recent study conducted in piglets demonstrated that supplementary dietary sialic acid was dose-dependently associated with faster learning, higher concentrations of protein-bound sialic acid in the frontal cortex, and 2–3-fold higher mRNA levels of 2 learning-related genes, GNE and ST8SIA4 (Wang et al., 2007).

The goals of the current study were to elucidate the structures of porcine milk OS (pMO) and to examine the changes in the content and composition during the complete lactation period using a HPLC-Chip/ToF system and nESI-FTICR mass spectrometry methods developed in our laboratory for human (Ninonuevo et al., 2006) and bovine (Tao et al., 2009) milks. Mass spectrometry with nanoflow liquid chromatography (nanoLC) provides a rapid quantitative method for glycan profiling. Each individual OS species was monitored to determine variation. The comparison of pMO against hMO and bMO was also performed.

MATERIALS AND METHODS

Materials

Nonporous graphitized carbon cartridges (150 mg of bed weight, 4 ml tube size) were obtained from Alltech (Deerfield, IL). Sodium borohydride (98%) was purchased from Sigma-Aldrich (St. Louis, MO). All reagents such as chloroform, acetonitrile, methanol, and alcohol were of analytical or HPLC grade.

Collection of Milk Samples

Colostrum and milk samples were collected from three second parity sows at various intervals from within a few hours after delivery until late lactation (day 24). Milk samples were obtained by manual expression after intravenous injection of 10 units oxytocin (Phoenix Scientific, St. Joseph, MO) and frozen immediately after collection at −80 °C.

Sample Preparation

Milk samples were totally thawed then 0.5 mL deionized water was added into an equal amount of raw milk followed by mixing and centrifugation at 4,000 g for 30 min at 4°C. After the top fat layer was removed, four volumes of chloroform/methanol (2v:1v) were added to the defatted milk samples. After centrifugation at 4,000 g for 30 min at 4°C, the upper layer was carefully transferred. Two volumes of ethanol were added to the mixture, which was incubated overnight at 4°C, followed by centrifugation at 4,000 g for 30 min at 4°C to remove denatured protein precipitate. The supernatant (milk OS-rich fraction) was freeze-dried with a speed vacuum. Native milk OS were reduced to alditol forms by using 1.0 M sodium borohydride in water and incubating overnight at 42°C. pMO were purified by solid-phase extraction using a nonporous graphitized carbon cartridge (GCC-SPE) and eluted with 20% acetonitrile in water (vol/vol) prior to mass spectrometry analysis.

Nano-Electrospray Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry (nESI-FTICR-MS) and Infrared Multiphoton Dissociation (IRMPD)

Mass spectra were obtained using nESI-FTICR-MS (IonSpec Corp., Irvine, CA) equipped with a 9.4 T superconducting magnet in both positive and negative ion modes. Cone voltages were maintained at 2000V - 3000V to obtain signals. Ions, which were transferred by the quadrupole ion guide prior to the ICR cell for detection, were accumulated in the hexapole. Tandem MS was performed with infrared multi-photon dissociation (IRMPD) with a 10.6 µm CO2 laser (Parallax Laser Inc., Waltham, MA) by transmitting the laser beam into the ICR cell through a BaF2 window to fragment isolated ions.

HPLC-Chip/TOF Mass Spectrometry

Milk OS fractions collected after solid-phase extraction with the graphitized carbon cartridge were analyzed using a microfluidic 6200 Series HPLC-chip/TOF MS instrument (Agilent Technologies, Santa Clara, CA). The microfluidic HPLC-Chip consists of an enrichment column, an LC separation column packed with porous graphitized carbon, and a nanoelectrospray tip. Separation was performed by a binary gradient A: 3% acetonitrile in 0.1% formic acid solution and B: 90% acetonitrile in 0.1% formic acid solution. The column was initially equilibrated and eluted with the flow rate at 0.3 µL for nanopump and 4 µL for capillary pump. The 65 min gradient was programmed as follows: 2.5 – 20 min, 0% - 16% B; 20 – 30 min, 16% – 44% B; 30 – 35 min, increased to 100% B; 45 min, 100% B; and finally, 0% B for 20 min to equilibrate the Chip column before the next sample injection. Each composition of milk OS was identified with an in-home program (Glycan Finder). Distinct compositions were identified based on accurate mass, retention times, and relative abundances. The instrument performed automatic tuning using a dual nebulizer electrospray source with an automated internal calibrant consisting of an unknown fluorinated compounds delivery system, which introduced a constant flow (100 mL/min) of calibrating solution containing the internal reference masses (m/z 118.0863, 322.0481, 622.0290, 922.0098, 221.9906, 1521.9715, 1821.9523, 2121.9332, 2421.9140, and 2721.8948) in positive mode.

RESULTS AND DISCUSSION

Mass spectrometry (MS) provides a rapid, quantitative system for glycomics analysis. We have recently reported the characterization of hMO by using nanoflow liquid chromatography (nanoLC) and high-performance MS (Ninonuevo et al., 2006). The integration of nanoLC with MS in a HPLC-chip/time-of-flight MS (HPLCchip/TOF MS) instrument allowed the rapid profiling of hMO and bMO in a precise and reproducible manner. The ultra high sensitivity of the instrumentation allows for a reduced sample requirement and the ability to detect lower abundance species. With this system, we were able to identify 40 bMO, most of which were in the sialylated forms (Tao et al., 2008), which doubled the number of total published bMO.

Comparison of Bovine and Porcine Milk OS

Our previous experience elucidating the OS structures in bMO (Tao et al., 2009) and hMO (Niñonuevo et al., 2006, 2008) facilitated the structural identification of pMO. Figure 1 shows a direct comparison of the HPLC chromatograms performed on the nanoLC Chip/TOF MS of pMO (Figure 1a) and bMO (Figure 1b). Based on the accurate masses and the retention times, we find strong similarities between bMO and pMO; the eight major OS peaks shown in the two chromatograms have complimentary retention times and masses. For example, with bMO peak 1 was determined to be lacto-N-neotetraose (LNnT) with m/z 710.275 [3Hex+1HexNAc+H]+ (Tao et al., 2009). The corresponding peak in the pMO chromatogram can be assigned to the same structure LNnT, since they share the same retention times and accurate masses. Structure and composition of LNnT is listed as oligosaccharide-10 (OS-10) in Table 1. The broad peak assigned as peak 5 with a retention time at around 19 – 21 min is another example. This OS is found in both bMO and pMO and corresponds to sialyllactose (NeuAc α(2–3)Galβ(1–4)Glc) (SL) (Tao et al., 2009), seen as OS-5 (Table 1). Both bovine and porcine milks have SL (molecular mass: 635.227) as the most abundant MO, which comprised more than 50% in total pMO followed by three common OS with m/z 709.264 (OS-10), 1074.400 (OS-21), and 1365.493 (OS-27) with intensities of 5% to 50% (Table 1). Tandem MS of the compounds was used to provide further confirmation that the compounds are identical (data not shown).

Figure 1.

Figure 1

Comparison of high-performance liquid chromatography-chip/time-of-flight-MS chromatograms of porcine (Panel a) and bovine (Panel b) milk oligosaccharides.

Table 1.

Common porcine milk oligosaccharides(OS) with compositions and relative abundances.

m/z (expt)1 m/z (cal) Hex Fuc HexNAc NeuAc NeuGc Retention
Time (min)
Rel. Abund.2 Existence in
BMO4
Proposed Structures5
1 490.190 490.190 2 1 11.471 graphic file with name nihms194333t1.jpg

2 506.184 506.185 3 10.429 graphic file with name nihms194333t2.jpg
3 506.185 506.185 3 9.216
4 506.186 506.185 3 15.065

5 635.227 635.227 2 1 17.348 graphic file with name nihms194333t3.jpg

6 635.227 635.227 2 1 11.67 graphic file with name nihms194333t4.jpg

7 636.249 636.248 2 2 14.572 graphic file with name nihms194333t5.jpg

8 676.252 676.254 1 1 1 20.68 graphic file with name nihms194333t6.jpg

9 692.238 692.249 1 1 1 12.574 3 graphic file with name nihms194333t7.jpg

10 709.264 709.264 3 1 15.304 graphic file with name nihms194333t8.jpg

11 750.289 750.291 2 2 14.598

12 797.279 797.280 3 1 22.182 graphic file with name nihms194333t9.jpg
13 797.280 797.280 3 1 19.915

14 871.315 871.317 4 1 16.459 graphic file with name nihms194333t10.jpg

15 912.347 912.343 3 2 19.692

16 967.348 967.349 1 1 2 18.47 graphic file with name nihms194333t11.jpg

17 1000.357 1000.359 3 1 1 26.043 graphic file with name nihms194333t12.jpg
18 1000.358 1000.359 3 1 1 22.346

19 1017.372 1017.375 4 1 1 14.033 graphic file with name nihms194333t13.jpg

20 1041.390 1041.386 2 2 1 20.637

21 1074.400 1074.396 4 2 19.693 graphic file with name nihms194333t14.jpg

22 1162.416 1162.412 4 1 1 26.272 graphic file with name nihms194333t15.jpg
23 1162.429 1162.412 4 1 1 25.784

24 1187.439 1187.444 2 1 2 1 24.319

25 1308.475 1308.470 4 1 1 1 25.585 graphic file with name nihms194333t16.jpg

26 1365.492 1365.492 4 2 1 26.398 graphic file with name nihms194333t17.jpg
27 1365.493 1365.492 4 2 1 25.185

28 1511.552 1511.550 4 1 2 1 24.565 graphic file with name nihms194333t18.jpg

29 1656.584 1656.587 4 2 2 28.852 graphic file with name nihms194333t19.jpg
1

expt and cal = experimental and calculated m/z values; Hex = hexose; Fuc = Fucose; HexNAc = N-acetylhexosamine; NeuAc = N-acetyl neuraminic acid; NeuGc =N-glycolylneuraminic acid.

2

relative abundances (%): ●> 50%, ◎ 5–50% , ○ <5%.

3

trace amount or not detectable in most of samples.

4

OS exist (★) or not exist (☆) in bovine milk. Proposed bovine structures are available. (Tao et al., 2008) (Tao et al., 2009)

5

Inline graphic and Inline graphic indicate glucose (Glc) and galactose (Gal), respectively; Inline graphic represent N-acetylglucosamine (GlcNAc); Inline graphic and Inline graphic represent N-acetyl neuraminic acid (NeuAc) and N-glycolylneuraminic acid (NeuGc), respectively. Inline graphic represent fucose (Fuc).

Characterization of Porcine Milk Oligosaccharides

Extracted ion chromatograms of the most abundant OS in porcine colostrum are shown in Figure 2. In general, there was significantly less structural diversity in the pMO compared to hMO as most masses yielded only one or two isomers. A similar lack of OS structural diversity is present in bovine milk as well (Tao et al., 2009). In contrast, up to eight isomers can be observed for some hMO (Niñonuevo et al., 2008).

Figure 2.

Figure 2

Base peak chromatogram (a) and extracted ion chromatograms (XIC) of selected ions (b–e) from a milk sample collected at farrowing from a single sow.

A summary of the pMO carbohydrate composition and retention times is listed in Table 1. Approximately 29 different OS were identified in porcine milk, compared to 40 in bovine milk (Tao et al., 2008) and over 130 in human milk (Bode, 2006). Under the conditions used in these experiments, acidic OS elute after approximately 20 min; SL has a retention time around 20 minutes. Another major anionic species has the retention time of around 26 min and corresponds to a bMO structure monosialyllacto-N-neohexaose (SLNnH) (Tao et al., 2009). Similar to bMO, pMO is composed primarily of anionic OS. Over 70% of the OS are comprised of sialylated OS in both bMO (Tao et al., 2009) and pMO, while for humans this value is between 5–20% (Niñonuevo et al., 2008). SIx fucosylated OS species were observed in pMO, albeit at very low abundance. Total fucosylation is around 1% of the OS abundance in porcine colostrum, and even less in mature porcine milk. Compared with up to 70% fucosylation of hMO, there is little or no fucosylated OS in the milk of domestic animals, including bovine (Tao et al., 2009) and porcine milks. Only one NeuGc-linked OS, α(2–6)NeuGc-lactosamine, was present in porcine colostrum. It was undetectable in mature porcine milk. Thus, compared to bovine milk, there are much less NeuGc-linked OS present in porcine milk.

Changes in Porcine Milk Oligosaccharides Across Lactation

HPLC chromatograms of pMO from colostrum and milk collected at farrowing, day 1, day 4, day 7, and day 24 lactation from the same sow is shown in Figure 3. The pMO peak at 15.5 min (See also Peak 1, Figure 1; OS-10, Table 1) corresponds to LNnT, which varies across lactation. LNnT is also a predominant OS in both bMO (Tao et al., 2009) and hMO (Niñonuevo et al., 2008). To illustrate the relative abundances of the major OS species in porcine milk, three milking points were chosen to represent early (farrow), mid (day 4) and late lactation (day 24) (Figure 4). SL, with m/z at 635.2 (OS-5, Table 1), was clearly the most dominant species (inset), with relative abundances 10-times higher than the next largest OS peak. The figure also shows that all major peaks decrease significantly from farrowing to mid-lactation and even some increase at late lactation.

Figure 3.

Figure 3

High-performance liquid chromatography-chip/time-of-flight-MS chromatograms of porcine milk oligosaccharides in samples collected at farrowing and days 1, 4, 7 and 24 of lactation from a single sow.

Figure 4.

Figure 4

Changes in oligosaccharide abundances for several oligosaccharide masses in samples collected at farrowing, day 4 and day 24 of lactation from a single sow.

To illustrate more clearly the behavior of the most abundant species, Figure 5 shows selected OS ion abundances of six of the predominant pMO across lactation. The left panels (a, b, c) represent neutral OS, while the right panels (d, e, f) represent sialylated OS. In general, there is a significant decline in OS during the first few days of lactation. LNnT decreases significantly (Figure 5a) as well as LNnH m/z 1074.398 (Figure 5c), SL (Figure 5d) and a large (as of yet unidentified) sialylated OS (Figure 5f). However, there are significant variations in the behavior of individual OS. The patterns of LNnT (Figure 5a), LNH (Figure 5c), and SL (Figure 5d) and the unidentified sialylated OS (Figure 5f) are very similar, with a significant drop during the first few days and an increase at day 24. The temporal change of these OS components are in agreement with Nakamura et al. (2003), who reported that the milk OS concentrations increase during late lactation. However, there are other pMO, such as that shown in Figure 5b that do not follow the same behavior, while another (Figure 5e) increased to a greater degree at day 24 than LNnT, LNH and SL. To determine whether variations among individuals were present, the milk samples of the two other sows were studied. Similar patterns of individual OS species from early to late lactation were observed (Data not shown).

Figure 5.

Figure 5

Variations in oligosaccharide abundances across lactation in samples collected from three sows. Panel a) 732 mass; Panel b) 871 mass; Panel c) 1074 mass; Panel d) 635 mass; Panel e) 797 mass, and Panel f)1365 mass. Panels a–c present neutral OS and panels d–f are sialylated OS.

Because sialylated OS appear to predominate in pig milk, the relative amount of sialylation of OS was determined across lactation. Shown in Figure 6 is the total abundance of sialylated OS relative to total OS (sialylated plus neutral). While the total proportion of sialylated OS content declines from 80% at farrowing to 60% in early lactation (days 4–7) to approximately 40% at the late lactation (day 24) (AS). This pattern resembles the pattern reported in bMO (Tao et al., 2009), however, in that publication only milk from early and mid-lactation were studied due to the longer lactation duration in the cow. This OS pattern differs from that of hMO, where sialylation is less abundant (∼10–25% of total OS) and remains relatively constant throughout lactation (Niñonuevo et al., 2008). Both bMO and pMO have SL as its most abundant component, whereas SL is a minor component in human milk. hMO are highly fucosylated, accounting for up to 70% of the OS species (Niñonuevo et al., 2008). While only 1% of pMO was fucosylated, this represents a significant amount. In contrast, we previously detected no fucosylated OS in bovine milk (Tao et al., 2008, 2009).

Figure 6.

Figure 6

Percent changes in abundances of sialylated oligosaccharides in colostrum and milk samples from day 4 and day 24.

DISCUSSION

Milk OS have at least two important potential functions: prevention of pathogen binding to the intestinal epithelial and stimulation of growth of beneficial bacterial (Newburg et al., 2005). Milk OS have been reported to differ among species (Urashima et al., 2001) and within human populations (Erney et al., 2000). The ratio of neutral-to-anionic (acidic) hMO is ∼ 70:20, whereas the opposite ratio is observed in bMO. hMO are highly fucosylated, whereas ∼70% of bMO are sialylated and no fucosylated bMO are present (Tao et al., 2009). pMO resemble bMO in being predominately sialylated, but unlike bMO, six fucose-containing pMO were detected suggesting a closer relationship between pMO and hMO than between bMO and hMO. However, the abundance and complexity of fucosylated OS in porcine milk is low relative to human milk.

There are OS that are common to hMO, bMO and pMO. LNnT is the major component of hMO and is also abundant in bMO and pMO. LNnT has been shown to be a prebiotic that stimulates the growth of the beneficial bifidobacterium (LoCascio et al., 2007; Ward et al., 2006. 2007) and is one of a few OS that increases during the late lactation period.

The mucosal surfaces of enterocytes within the mammalian intestine contain glycoconjugates that participate in cellular interactions, communication with the cell’s surroundings and may be exploited as receptor analogs for pathogens (Newburg, 1999). Oligosaccharides found within colostrum and milk potentially may serve as receptors for pathogens thus inhibiting their attachment to mucosal surfaces (Newburg, 2009). Therefore a relationship has been proposed between the structure and function of oligosaccharides and their ability to decrease enteric infection (Newburg et al., 2005).

Many viruses are dependent upon sialic acid for binding to cells. For example, rotavirus (RV) cell attachment and entry are considered as either dependent on or independent of the presence of sialic acids, for example N-acetylneuraminic acid (Neu5Ac), in cell-surface glycoconjugates such as gangliosides (Isa et al., 2006). This relationship between virus and sialic acids has provided the basis for the now widely accepted RV classification into sialidase-sensitive and sialidase-insensitive strains. Human rotaviruses have been typically classified as sialidase-insensitive whereas the infectivity of RV that commonly infect calves and piglets are sialic acid-dependent. Their infectivity can be blocked by neuraminidase treatment (Isa et al., 2006). Thus, the high concentrations of sialylated-OS in bovine and porcine milks may confer protection for the neonates of these species.

However, data obtained from a recent study suggest that the commonly used RV classification into sialidase-sensitive and sialidase-insensitive strains does not encapsulate the nature of human RVWa interactions with its host cell receptors (Haselhorst et al., 2009). Neuraminidase treatment of Wa generated novel cellular receptors leading to increased infectivity, suggesting that Wa virus is not sialic acid independent, contrary to the widely accepted paradigm (Haselhorst et al., 2009; Isa et al., 2006). The data of Haselhorst and colleagues (2009) suggest that a RV classification system based on ganglioside specificity rather than sialidase sensitivity may be required.

In addition, the type of fucosylated hMO may impact the ability to avoid infection (Morrow et al., 2004; Newburg et al., 2005). There are reports, for example, that fucosylated OS inhibit diarrhea caused by the action of the heat stable toxins of Escherichia coli, Campylobacter jejune, Calicivirus and others (Morrow et al., 2004; Newburg et al., 2004; Ruiz-Palacios et al., 2003).

In summary, the HPLC-chip/TOF MS system allowed for identification of nearly 30 different OS species in porcine milk. The predominant OS in porcine milk as in bovine milk was SL, possibly conferring protection of neonates against infection. An understanding of the anti-infective properties of porcine milk OS (PMO) is important given the reported increase in antibiotic resistant microbes in health pigs (Nulsen et al., 2007) and the recommendations against the use of low-dose antibiotics as growth-promoters in Europe Union (Aarestrup et al., 2001).

ACKNOWLEDGMENTS

Funding provided by the California Dairy Research Foundation, Dairy Management Incorporated, the University of California Discovery, and the National Institutes of Health (R01 HD-061929to SMD) and (R01 049077 and HD061923 to CBL) is gratefully acknowledged.

REFERENCES

  1. Aarestrup FM, Seyfarth AM, Emborg H-D, Pedersen K, Hendriksen RS, Bager FE. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob. Agents Chemother. 2001;45:2054–2059. doi: 10.1128/AAC.45.7.2054-2059.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baker DH. Animal models in nutrition research. J. Nutr. 2008;138:391–396. doi: 10.1093/jn/138.2.391. [DOI] [PubMed] [Google Scholar]
  3. Bode L, Kunz C, Muhly-Reinholz M, Mayer K, Seeger W, Rudloff S. Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides. Thromb. Haemost. 2004;92:1402–1410. doi: 10.1160/TH04-01-0055. [DOI] [PubMed] [Google Scholar]
  4. Boehm G, Stahl B, Jelinek J, Knol J, Miniello V, Moro GE. Prebiotic carbohydrates in human milk and formulas. Acta Paediatr. Suppl. 2005;94:18–21. doi: 10.1111/j.1651-2227.2005.tb02149.x. [DOI] [PubMed] [Google Scholar]
  5. Boehm G, Stahl B. Oligosaccharides from milk. J. Nutr. 2007;137(3 Suppl 2) doi: 10.1093/jn/137.3.847S. 847S–849S. [DOI] [PubMed] [Google Scholar]
  6. Engfer MB, Stahl B, Finke B, Sawatzki G, Daniel H. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr. 2000;71:1589–1596. doi: 10.1093/ajcn/71.6.1589. [DOI] [PubMed] [Google Scholar]
  7. Erney RM, Malone WT, Skelding MB, Marcon AA, Kleman-Leyer KM, O'Ryan ML, Ruiz-Palacios G, Hilty MD, Pickering LK, Prieto PA. Variability of human milk neutral oligosaccharides in a diverse population. Pediatr. Gastroenterol. Nutr. 2000;30:181–192. doi: 10.1097/00005176-200002000-00016. [DOI] [PubMed] [Google Scholar]
  8. Gal B, Ruano MJ, Puente R, García-Pardo LA, Rueda R, Gil A, Hueso P. Developmental changes in UDP-Nacetylglucosamine 2-epimerase activity of rat and guinea-pig liver. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 1997;118:13–15. doi: 10.1016/s0305-0491(97)00016-3. [DOI] [PubMed] [Google Scholar]
  9. German JB, Freeman SL, Lebrilla CB, Mills DA. Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria. Nestle Nutr. Workshop Ser. Pediatr. Program. 2008;62:205–218. doi: 10.1159/000146322. discussion 218–222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Haselhorst T, Fleming FE, Dyason JC, Hartnell RD, Yu X, Holloway G, Santegoets K, Kiefel MJ, Blanchard H, Coulson BS, von Itzstein M. Sialic acid dependence in rotavirus host cell invasion. Nature Chem. Biol. 2009;5:91–93. doi: 10.1038/nchembio.134. [DOI] [PubMed] [Google Scholar]
  11. Isa A, Arias CF, López S. Role of sialic acids in rotavirus infection. Glycoconj. J. 2006;23:27–37. doi: 10.1007/s10719-006-5435-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kunz C, Rudloff S. Potential anti-inflammatory and anti-infectious effects of human milk oligosaccharides. Adv. Exp. Med. Biol. 2008;606:455–465. doi: 10.1007/978-0-387-74087-4_18. [DOI] [PubMed] [Google Scholar]
  13. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu. Rev. Nutr. 2000;20:699–722. doi: 10.1146/annurev.nutr.20.1.699. [DOI] [PubMed] [Google Scholar]
  14. LoCascio RG, Ninonuevo MR, Freeman SL, Sela DA, Grimm R, Lebrilla CB, Mills DA, German JB. Glycoprofiling of bifidobacteria consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J. Agric. Food Chem. 2007;55:8914–8919. doi: 10.1021/jf0710480. [DOI] [PubMed] [Google Scholar]
  15. Morgan BL, Winick M. Effects of essential fatty acid deficiency during late gestation on brain N-acetylneuraminic acid metabolism and behaviour in the progeny. Br. J. Nutr. 1981;46:223–230. doi: 10.1079/bjn19810027. [DOI] [PubMed] [Google Scholar]
  16. Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero ML, Meinzen-Derr JK, Farkas T, Chaturvedi P, Pickering LK, Newburg DS. Human milk oligosaccharide blood group epitopes and innate immune protection against campylobacter and calicivirus diarrhea in breastfed infants. Adv. Exp. Med. Biol. 2004;554:443–446. doi: 10.1007/978-1-4757-4242-8_61. [DOI] [PubMed] [Google Scholar]
  17. Nakamura T, Kawase H, Kimura K, Watanabe Y, Ohtani M, Arai I, Urashima T. Concentrations of sialyloligosaccharides in bovine colostrum and milk during the prepartum and early lactation. J. Dairy Sci. 2003;86:1315–1320. doi: 10.3168/jds.S0022-0302(03)73715-1. [DOI] [PubMed] [Google Scholar]
  18. Nakano T, Sugawara M, Kawakami H. Sialic acid in human milk: composition and functions. Acta Paediatr. Taiwan. 2001;42:11–17. [PubMed] [Google Scholar]
  19. Newburg D. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J. Anim. Sci. 2009;87:26–34. doi: 10.2527/jas.2008-1347. [DOI] [PubMed] [Google Scholar]
  20. Newburg DS, Ruiz-Palacios GM, Altaye M, Chaturvedi P, Meinzen-Derr J, Guerrero ML, Morrow AL. Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiology. 2004;14:253–263. doi: 10.1093/glycob/cwh020. [DOI] [PubMed] [Google Scholar]
  21. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu. Rev. Nutr. 2005;25:37–58. doi: 10.1146/annurev.nutr.25.050304.092553. [DOI] [PubMed] [Google Scholar]
  22. Niñonuevo MR, Park Y, Yin H, Zhang J, Ward RE, Clowers BH, German JB, Freeman SL, Killeen K, Grimm R, Lebrilla CB. A strategy for annotating the human milk glycome. J. Agric. Food Chem. 2006;54:7471–7480. doi: 10.1021/jf0615810. [DOI] [PubMed] [Google Scholar]
  23. Niñonuevo MR, Perkins PD, Francis J, Lamotte LM, LoCascio RG, Freeman SL, Mills DA, German JB, Grimm R, Lebrilla CB. Daily variations in oligosaccharides of human milk determined by microfluidic chips and mass spectrometry. J. Agric. Food Chem. 2008;56:618–626. doi: 10.1021/jf071972u. [DOI] [PubMed] [Google Scholar]
  24. Nulsen MF, Mor MB, Lawton DEB. Antibiotic resistance among indicator bacteria isolated from healthy pigs in New Zealand. New Zealand Vet. J. 2008;56:29–35. doi: 10.1080/00480169.2008.36801. [DOI] [PubMed] [Google Scholar]
  25. Patterson JK, Lei XG, Miller DD. The pig as an experimental model for elucidating the mechanisms governing dietary influence on mineral absorption. Exper. Biol. Med. 2008;233:651–664. doi: 10.3181/0709-MR-262. [DOI] [PubMed] [Google Scholar]
  26. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118:511–521. doi: 10.1542/peds.2005-2824. [DOI] [PubMed] [Google Scholar]
  27. Pond WG, Boleman SL, Fiorotto ML, Ho H, Knabe DA, Mersmann HJ, Savell JW, Su DR. Perinatal ontogeny of brain growth in the domestic pig. Proc. Soc. Exp. Biol. Med. 2000;223:102–108. doi: 10.1177/153537020022300114. [DOI] [PubMed] [Google Scholar]
  28. Rivero-Urgell M, Santamaria-Orleans A. Oligosaccharides: application in infant food. Early Hum. Dev. 2001;65 Suppl:S43–S52. doi: 10.1016/s0378-3782(01)00202-x. [DOI] [PubMed] [Google Scholar]
  29. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J. Biol. Chem. 2003;278:14112–141120. doi: 10.1074/jbc.M207744200. [DOI] [PubMed] [Google Scholar]
  30. Svennerholm L, Bostrom K, Jungbjer B, Olsson L. Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J. Neurochem. 1994;63:1802–1811. doi: 10.1046/j.1471-4159.1994.63051802.x. [DOI] [PubMed] [Google Scholar]
  31. Tao N, DePeters EJ, Freeman S, German JB, Grimm R, Lebrilla CB. Bovine milk glycome. J. Dairy Sci. 2008;91:3768–3778. doi: 10.3168/jds.2008-1305. [DOI] [PubMed] [Google Scholar]
  32. Urashima T, Saito T, Nakamura T, Messer M. Oligosaccharides of milk and colostrum in non-human mammals. Glycoconjugate J. 2001;18:357–371. doi: 10.1023/a:1014881913541. [DOI] [PubMed] [Google Scholar]
  33. Wang B, Miller JB, McNeil Y, McVeagh P. Sialic acid concentration of brain gangliosides: variation among eight mammalian species. Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 1998;119:435–439. doi: 10.1016/s1095-6433(97)00445-5. [DOI] [PubMed] [Google Scholar]
  34. Wang B, Yu B, Karim M, Hu H, Sun Y, McGreevy P, Petocz P, Held S, Brand-Miller J. Dietary sialic acid supplementation improves learning and memory in piglets. Am. J. Clin. Nutr. 2007;85:561–569. doi: 10.1093/ajcn/85.2.561. [DOI] [PubMed] [Google Scholar]
  35. Ward RE, Niñonuevo M, Mills DA, Lebrilla CB, German JB. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl. Environ. Microbiol. 2006;72:4497–4499. doi: 10.1128/AEM.02515-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ward RE, Niñonuevo M, Mills DA, Lebrilla CB, German JB. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res. 2007;51:1398–1405. doi: 10.1002/mnfr.200700150. [DOI] [PubMed] [Google Scholar]
  37. Warren CD, Chaturvedi P, Newburg AR, Oftedal OT, Tilden CD, Newburg DS. Comparison of oligosaccharides in milk specimens from humans and twelve other species. Adv. Exp. Med. Biol. 2001;501:325–332. doi: 10.1007/978-1-4615-1371-1_40. [DOI] [PubMed] [Google Scholar]

RESOURCES